31 related articles for article (PubMed ID: 8012933)
1. All eyes on Eya: A unique transcriptional co-activator and phosphatase in cancer.
Hughes CJ; Alderman C; Wolin AR; Fields KM; Zhao R; Ford HL
Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189098. PubMed ID: 38555001
[TBL] [Abstract][Full Text] [Related]
2. Multiomics Study of a Novel Naturally Derived Small Molecule, NSC772864, as a Potential Inhibitor of Proto-Oncogenes Regulating Cell Cycle Progression in Colorectal Cancer.
Mokgautsi N; Kuo YC; Chen CH; Huang YJ; Wu ATH; Huang HS
Cells; 2023 Jan; 12(2):. PubMed ID: 36672275
[TBL] [Abstract][Full Text] [Related]
3. Significant position of C-myc in colorectal cancer: a promising therapeutic target.
Tan L; Peng D; Cheng Y
Clin Transl Oncol; 2022 Dec; 24(12):2295-2304. PubMed ID: 35972682
[TBL] [Abstract][Full Text] [Related]
4. Genomic landscape of colorectal carcinogenesis.
Kim JC; Bodmer WF
J Cancer Res Clin Oncol; 2022 Mar; 148(3):533-545. PubMed ID: 35048197
[TBL] [Abstract][Full Text] [Related]
5. Galloflavin Relieves the Malignant Behavior of Colorectal Cancer Cells in the Inflammatory Tumor Microenvironment.
Guo L; Yang Y; Sheng Y; Wang J; Li W; Zhou X; Ruan S; Han C
Front Pharmacol; 2021; 12():752118. PubMed ID: 34955826
[No Abstract] [Full Text] [Related]
6. MiR-138 is a potent regulator of the heterogenous MYC transcript population in cancers.
Desi N; Teh V; Tong QY; Lim CY; Tabatabaeian H; Chew XH; Sanchez-Mejias A; Chan JJ; Zhang B; Pitcheshwar P; Siew BE; Wang S; Lee KC; Chong CS; Cheong WK; Lieske B; Tan IJ; Tan KK; Tay Y
Oncogene; 2022 Feb; 41(8):1178-1189. PubMed ID: 34937878
[TBL] [Abstract][Full Text] [Related]
7. The prognostic role of c-MYC amplification in schistosomiasis-associated colorectal cancer.
Pan W; Wang W; Huang J; Lu K; Huang S; Jiang D; Bu D; Liu J; Jing H; Yao J; Hou Y
Jpn J Clin Oncol; 2020 Apr; 50(4):446-455. PubMed ID: 32297641
[TBL] [Abstract][Full Text] [Related]
8. The Eya phosphatase: Its unique role in cancer.
Zhou H; Zhang L; Vartuli RL; Ford HL; Zhao R
Int J Biochem Cell Biol; 2018 Mar; 96():165-170. PubMed ID: 28887153
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate driver genes in common focal chromosomal aberrations of microsatellite stable colorectal cancer.
Burghel GJ; Lin WY; Whitehouse H; Brock I; Hammond D; Bury J; Stephenson Y; George R; Cox A
PLoS One; 2013; 8(12):e83859. PubMed ID: 24367615
[TBL] [Abstract][Full Text] [Related]
10. AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer.
Jackstadt R; Röh S; Neumann J; Jung P; Hoffmann R; Horst D; Berens C; Bornkamm GW; Kirchner T; Menssen A; Hermeking H
J Exp Med; 2013 Jul; 210(7):1331-50. PubMed ID: 23752226
[TBL] [Abstract][Full Text] [Related]
11. K-Ras and B-Raf oncogenes inhibit colon epithelial polarity establishment through up-regulation of c-myc.
Magudia K; Lahoz A; Hall A
J Cell Biol; 2012 Jul; 198(2):185-94. PubMed ID: 22826122
[TBL] [Abstract][Full Text] [Related]
12. Functional genomics identifies therapeutic targets for MYC-driven cancer.
Toyoshima M; Howie HL; Imakura M; Walsh RM; Annis JE; Chang AN; Frazier J; Chau BN; Loboda A; Linsley PS; Cleary MA; Park JR; Grandori C
Proc Natl Acad Sci U S A; 2012 Jun; 109(24):9545-50. PubMed ID: 22623531
[TBL] [Abstract][Full Text] [Related]
13. Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma.
Torchia EC; Caulin C; Acin S; Terzian T; Kubick BJ; Box NF; Roop DR
Oncogene; 2012 May; 31(21):2680-90. PubMed ID: 21963848
[TBL] [Abstract][Full Text] [Related]
14. MYC and metastasis.
Wolfer A; Ramaswamy S
Cancer Res; 2011 Mar; 71(6):2034-7. PubMed ID: 21406394
[TBL] [Abstract][Full Text] [Related]
15. Moderate amplifications of the c-myc gene correlate with molecular and clinicopathological parameters in colorectal cancer.
Masramon L; Arribas R; Tórtola S; Perucho M; Peinado MA
Br J Cancer; 1998 Jun; 77(12):2349-56. PubMed ID: 9649157
[TBL] [Abstract][Full Text] [Related]
16. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.
Yang JL; Ow KT; Russell PJ; Ham JM; Crowe PJ
Ann Surg Oncol; 1996 Nov; 3(6):574-9. PubMed ID: 8915491
[TBL] [Abstract][Full Text] [Related]
17. Is mucinous carcinoma of the colorectum a distinct genetic entity?
Hanski C
Br J Cancer; 1995 Dec; 72(6):1350-6. PubMed ID: 8519644
[TBL] [Abstract][Full Text] [Related]
18. Investigation of c-myc oncogene amplification in colorectal cancer.
Kozma L; Kiss I; Szakáll S; Ember I
Cancer Lett; 1994 Jun; 81(2):165-9. PubMed ID: 8012933
[TBL] [Abstract][Full Text] [Related]
19. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
